Anastrozole Mono Acid

Anastrozole Mono Acid is a pharmaceutical compound that is used as an aromatase inhibitor. It is primarily used in the treatment of breast cancer in postmenopausal women. The compound works by blocking the enzyme aromatase, which is responsible for the conversion of androgens to estrogens. By blocking this process, Anastrozole Mono Acid reduces the level of estrogen in the body, which helps to slow down the growth of breast cancer cells. Anastrozole Mono Acid is an orally administered compound that is typically prescribed as a 1 mg tablet. It is typically taken once per day for the duration of treatment. The compound is metabolized in the liver and excreted through the kidneys. As with any pharmaceutical compound, there are potential side effects associated with the use of Anastrozole Mono Acid. These can include hot flashes, nausea, headaches, and joint pain. In rare cases, more serious side effects such as liver damage and osteoporosis may occur. In terms of chemical information, Anastrozole Mono Acid has a molecular formula of C17H19N5 and a molecular weight of 293.37 g/mol. It has a melting point of 81-82°C and is soluble in ethanol, methanol, and dimethyl sulfoxide. The compound is a white to off-white crystalline powder that is stable under normal conditions. It should be stored in a cool, dry place away from direct sunlight.